5-Amino-1MQ vs Mazdutide — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that regulates NAD+ metabolism and energy expenditure in adipose tissue. By blocking NNMT, 5-Amino-1MQ raises intracellular NAD+ and SAM levels, pushing stem cells toward muscle and bo...
Calculate 5-Amino-1MQ dose →Mazdutide (IBI362) is a once-weekly GLP-1/glucagon receptor dual agonist developed by Innovent Biologics. By activating both receptors simultaneously, it combines the appetite suppression and insulin-sensitizing effects of GLP-1 agonism with the fat-oxidizing and energy-expenditu...
Calculate Mazdutide dose →| Parameter | 5-Amino-1MQ | Mazdutide |
|---|---|---|
| Category | Metabolic & Mitochondrial | Metabolic & Mitochondrial |
| Research | Preclinical | Phase III (China) |
| Half-Life | ~4 hours (estimated) | ~7 days |
| Typical Dose | 50 mg | 3–9 mg |
| Frequency | Once daily | Once weekly |
| Route | Oral | Subcutaneous (weekly) |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.